CARDIOVASCULAR EFFECTS OF ORAL ANTIVIRAL TREATMENT FOR NON-CARDIAC HCV PATIENTS

Effect of Direct Acting Anti-Hepatitis C Drugs on the Heart

Pulmonary complications of antiviral drugs (Sofosbuvir and Daclatasvir) used in treatment of patients with chronic hepatitis C virus

Short term follow-up of clinical outcome of patients with heart failure and associated hepatitis C virus infection

Lipid response in Hcv patients treated by direct acting antivirals

Effect of Direct-Acting Antiviral Therapy on Lipid Profile in Egyptian Patients with Chronic Hepatitis C Infection

Effect of Direct-Acting Antivirals on Lipid and Glucose Metabolism in Chronic HCV Patients

Biochemical Hepatic Changes in Chronic Hepatitis C Patients Induced by Sofosbuvir and Daclatasvir with or without Ribavirin Regimens

Hematological Effects of Antiviral Drugs for Hepatitis C Virus

TYPES AND PREDICTORS OF INTERFERON/RIBAVIRIN INDUCED CARDIAC COMPLICATIONS IN THE EGYPTIAN PATIENTS WITH CHRONIC HEPATITIS C VIRUS